喹那普利可降低老年高血压糖尿病患者的动脉血压并改善代谢控制。 - Suppr | 超能文献

Quinapril reduces arterial blood pressure and improves metabolic control in elderly hypertensive diabetic patients.

作者信息

Paolisso G, Gambardella A, Verza M, Varricchio M

出版信息

Diabete Metab. 1990 May-Jun;16(3):264-5.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Quinapril reduces arterial blood pressure and improves metabolic control in elderly hypertensive diabetic patients.喹那普利可降低老年高血压糖尿病患者的动脉血压并改善代谢控制。

Diabete Metab. 1990 May-Jun;16(3):264-5.

2

Quinapril reduces microalbuminuria in essential hypertensive and in diabetic hypertensive subjects.喹那普利可降低原发性高血压患者和糖尿病高血压患者的微量白蛋白尿。

Am J Hypertens. 1995 Aug;8(8):808-14. doi: 10.1016/0895-7061(95)00143-D.

3

[Tonocardin in complex treatment of diabetes mellitus concurrent with hypertension].

Ter Arkh. 2002;74(12):38-41.

4

Comparison of effects of quinapril and metoprolol on glycaemic control, serum lipids, blood pressure, albuminuria and quality of life in non-insulin-dependent diabetes mellitus patients with hypertension. Swedish Quinapril Group.喹那普利与美托洛尔对非胰岛素依赖型糖尿病合并高血压患者血糖控制、血脂、血压、蛋白尿及生活质量影响的比较。瑞典喹那普利研究组。

J Intern Med. 1998 Aug;244(2):95-107. doi: 10.1046/j.1365-2796.1998.00319.x.

5

Antihypertensive therapy in diabetic patients. The use of indapamide.

Am J Med. 1988 Jan 29;84(1B):89-91.

6

A postmarketing surveillance evaluation of quinapril in 3742 Canadian hypertensive patients: the ACCEPT Study. Accupril Canadian Clinical Evaluation and Patient Teaching.对3742例加拿大高血压患者进行的喹那普利上市后监测评估：ACCEPT研究。喹那普利加拿大临床评估与患者教育。

Clin Ther. 1994 Sep-Oct;16(5):838-53.

7

[Effect of enalapril on clinical and metabolic characteristics in patients with non-insulin-dependent diabetes and arterial hypertension].依那普利对非胰岛素依赖型糖尿病合并动脉高血压患者临床及代谢特征的影响

Ter Arkh. 2000;72(12):63-4.

8

Modification of cardiovascular risk factors during antihypertensive treatment: a multicentre trial with quinapril.降压治疗期间心血管危险因素的改变：喹那普利的一项多中心试验

J Int Med Res. 1993 Jan-Feb;21(1):15-25. doi: 10.1177/030006059302100102.

9

[Spirapril - a new long-acting ACE inhibitor: efficacy and safety in patients with arterial hypertension in combination with diabetes mellitus and impaired kidney function].[螺普利——一种新型长效血管紧张素转换酶抑制剂：对合并糖尿病及肾功能损害的动脉高血压患者的疗效与安全性]

Ter Arkh. 2000;72(10):82-6.

10

[Evaluation of the effect of enalapril in hypertensive patients with non-insulin-dependent diabetes mellitus].[依那普利对非胰岛素依赖型糖尿病高血压患者疗效的评估]

Clin Ter. 1993 Jul;143(1):19-21.

引用本文的文献

1

Efficacy and Safety of Quinapril 40mg Once Daily as Monotherapy for Patients with Poorly Controlled Hypertension : The EUREKA Study.喹那普利 40mg 每日一次单药治疗血压控制不佳的患者的疗效和安全性：EUREKA 研究。

Clin Drug Investig. 2000;20(2):81-8. doi: 10.2165/00044011-200020020-00002.

2

Quinapril. A review of its pharmacological properties, and therapeutic efficacy in cardiovascular disorders.喹那普利。对其药理特性及在心血管疾病中的治疗效果的综述。

Drugs. 1991 Mar;41(3):378-99. doi: 10.2165/00003495-199141030-00006.